MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Multi-kinase Abelson (c-Abl) and Discoidin Domain Receptors (DDR1/2) inhibitors, Nilotinib, alters CSF soluble TREM2 (sTREM2) in individuals with Parkinson’s Disease

    F. Pagan, M. Hebron, B. Wilmarth, Y. Torres-Yaghi, E. Mundel, N. Yusuf, C. Moussa (Washington, DC, USA)

    Objective: Our objective was to examine the effects of broad-based tyrosine kinase inhibition in cerebrospinal fluid biomarkers. Background: Nilotinib is a broad-based tyrosine kinase inhibitor…
  • 2019 International Congress

    Management of Akinesia in Parkinson’s Disease with Apomorphine Subcutaneous Injection

    F. Rakhimov, B. Sultanov (Tashkent, Uzbekistan)

    Objective: To assess the effect of apomorphine on time-to-ON in PD patients with morning akinesia. Background: In patients with motor fluctuations complicating Parkinson's disease (PD), delays in time-to-ON…
  • 2019 International Congress

    3 Year QoL Results for PD Patients Receiving DBS: Product Surveillance Registry

    M. Schiess, S. Palfi, J. Azulay, A. Lopez Rios, H. Xiong, K. Sandberg, JK. Krauss (Houston, TX, USA)

    Objective: Summarize improvement in quality of life (QoL) by comparing scores from the EQ-5D questionnaire, five level response version (EQ-5D-5L) summary index and visual analog scale (EQ-VAS) obtained for…
  • 2019 International Congress

    Dynamics of Device-based Treatments for Parkinson´s Disease in Germany from 2010 – 2017

    L. Tönges, D. Bartig, C. Krogias, D. Richter (Bochum, Germany)

    Objective: Analyze the patient profiles and dynamics of utilization of Continuous Subcutaneous Apomorphine Infusion (CSAI), Levodopa-carbidopa Intestinal Gel (LCIG), and Deep Brain Stimulation (DBS) for…
  • 2019 International Congress

    A Case Presentation of Wilson’s Disease

    D. Al Elwany, S. Ahmed, H. Deraz, C. Ragaey (Cairo, Egypt)

    Objective: To study clinical presentations of Wilson’s disease. Background: Wilson disease (WD; also known as hepatolenticular degeneration) is an autosomal-recessive disorder caused by mutation in…
  • 2019 International Congress

    Abnormal Gait in Cerebrotendenious Xanthomatosis a case report

    H. Amer, S. Ali, S. Sherif, S. El-Jaafary (Cairo, Egypt)

    Objective: To identify patients with Cererotendenious xanthomatosis. To present the neurological spectrum of the disease. Background: Cerebrotendenious xanthomatosis is a rare lipid storage disease due…
  • 2019 International Congress

    A Korean case of Fragile X-associated mild ataxia without tremor

    WW. Lee, BK. Kim, O. Kwon, JM. Park, JJ. Lee, K. Kang (Seoul, Republic of Korea)

    Objective: To report a case of Fragile X-associated tremor/ataxia syndrome (FXTAS) only with mild ataxia. Background: FXTAS is a neurodegenerative disorder caused by the CGG trinucleotide…
  • 2019 International Congress

    Need of next generation sequencing technology to de-convolute autosomal recessive cerebellar ataxias in India

    S. Shakya, R. Kumari, A. Garg, A. Srivastava, M. Faruq (New Delhi, India)

    Objective: Comparison of two next generation platform to screen ARCA patients in Indian population Background: India is deficient with the molecular screening of the ARCAs.…
  • 2019 International Congress

    Permanent chorea in 76-years-old female with poorly controlled diabetes

    F. Abu Ahmad, A. Socher, A. Gadoth, O. Aizenstein, A. Hilel, R. Hurvitz-Alon, N. Giladi, T. Gurevich (Tel Aviv, Israel)

    Objective: To present a unique case of a patient with hyperglycemic associated chorea showing no improvement during a long-term follow-up, despite a strict glycemic control.…
  • 2019 International Congress

    An adult type Niemann-Pick disease type C family: Huntington’s disease-like expression

    I. Toyoshima, F. Takeda, C. Wada (Yurihonjo, Japan)

    Objective: We present a family with Niemann-Pick disease type C (NPC) expressing Huntington's disease-like involuntary movements. The process for the diagnosis may be a good…
  • « Previous Page
  • 1
  • …
  • 122
  • 123
  • 124
  • 125
  • 126
  • …
  • 217
  • Next Page »
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley